Why is Beta Drugs Ltd falling/rising?

As of 16-Jul, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,677.00, which reflects a decrease of 53.0 points or 3.06%. The stock has underperformed its sector today by 2.79%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -4.93%, while its performance over the past month is down by 6.99%. Despite a strong long-term performance with a 39.87% increase over the past year and a remarkable 2617.88% rise over five years, the recent trends indicate a significant downturn. There is a noted increase in investor participation, with delivery volume rising by 25.98% against the 5-day average, suggesting some interest in the stock despite its current price drop. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.
In the broader market context, Beta Drugs Ltd's short-term performance has been notably worse than the benchmark Sensex, which has only declined by 1.04% over the past week. While the Sensex has shown a positive return of 1.06% over the last month, Beta Drugs Ltd has struggled significantly, indicating a divergence in performance. This underperformance relative to the benchmark may contribute to investor sentiment and the stock's current downward trajectory.